5MRD

Options Traders Make a Beeline Toward Booming PolarityTE Stock

Cantor Fitzgerald thinks PTE stock will rally up to $65

Dec 19, 2018 at 3:01 PM
facebook X logo linkedin


Options volume is accelerated on PolarityTE Inc (NASDAQ:PTE) this afternoon, as the healthcare stock looks to snap its three day losing streak. Nearly 1,715 options are on the tape -- four times the average intraday amount -- with PTE shares up 8% at $14.52.

The upside comes following news the regenerative tissue specialist has inked a deal with the University Hospitals Cleveland Medical Center to offer its SkinTE product at the medical center's burn care and chronic non-healing wounds facilities. Plus, Cantor Fitzgerald reiterated its "overweight" rating and $65 price target -- a 346% premium to current trading levels.

Short-term options traders, meanwhile, are targeting a quick reversal for PTE stock. Amid relatively light absolute volume, the equity's December 17.50 put is likely being bought to open for a volume-weighted average price of $2.30. If this is the case, breakeven for the put buyers at the close this Friday, Dec. 21, is $15.20 (strike less premium paid).

Looking at the charts, PTE stock has struggled since its June 21 peak at $41.22, down 65%. More recently, the shares found their footing near $12.50, but subsequent rallies from here have stalled out near the formerly supportive $17.50 region, as well as the stock's descending 80-day moving average.

pte stock daily chart dec 19

 

The $25K Day Trading Barrier is Gone

The long-standing Pattern Day Trader (PDT) rule that required many traders to maintain a $25,000 account balance is no longer standing in the way.

That means more traders can actively pursue short-term opportunities without the barrier that kept so many on the sidelines.

Now it's all about having the right strategy.

Dynamite Day Trading Signals helps you hit the ground running with up 2 options trade alerts per week, built to capture fast-moving opportunities.  

👉 Sign up now to receive the next trade

MR content page
 
 
 
 

Follow us on X, Follow us on Twitter